Instil Bio, Inc. (TIL)
9.16
-0.34
(-3.58%)
USD |
NASDAQ |
Feb 20, 16:00
9.11
-0.05
(-0.55%)
After-Hours: 20:00
Instil Bio SG&A Expense (Quarterly) : 5.895M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Oramed Pharmaceuticals, Inc. | 1.274M |
| ACADIA Pharmaceuticals, Inc. | 133.40M |
| Alnylam Pharmaceuticals, Inc. | 325.37M |
| Savara, Inc. | 9.627M |
| BioMarin Pharmaceutical, Inc. | 268.40M |